Glenis Willmott, a leading MEP on health, has lambasted plans for pharmaceuticals and medical devices to be overseen by the Industry Commissioner in Juncker’s new team.
“I find it hard to believe. Medicines and medical devices are first and foremost about improving and protecting people’s health. Of course Europe’s pharmaceutical and medical technology industries are important to our economy, but our first priority must be health.”
“When I was negotiating the transparency laws for clinical trial results, it was DG Enterprise that wanted to water the rules down. Now they will be overseeing the European Medicines Agency as it implements the transparency regime, which is frankly concerning.”
“Following the breast implant scandal people expect stronger regulation of medical devices, regulation that protects patients. Clearly medical devices should be the responsibility of the Heath Commissioner.”
“This was a bad decision from President Juncker, I hope he will quickly come to his senses and rectify it.”